What is management’s responsibility in the implementation of approaches to the new QMSR? In this segment from Drug Delivery Leader's live event, consultant Laurie Brager Auerbach underscores the criticality of management commitment to and engagement in the process. Watch the segment: https://lnkd.in/d-sEmeaY
Drug Delivery Leader’s Post
More Relevant Posts
-
Couldn't join the "𝗛𝗼𝘄 𝘁𝗼 𝗘𝗻𝘀𝘂𝗿𝗲 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 𝗔𝗻𝗻𝗲𝘅 𝟭" PharmaLex webinar? No problem - we recorded it for you! 🚀 Access this #webinar and learn about these challenges, based on our experiences within the industry, and how companies can have a structured approach helping them to make the assessment. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🎙️Patrick Nieuwenhuizen, Director Principal Consultant at Cencora PharmaLex 🎙️Londa R., Quality Director, Quality Management & Compliance at Cencora PharmaLex 𝗞𝗲𝘆 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀: ➡️ QRM; ➡️ CCS; ➡️ Case study examples of aging facilities; ➡️ Annex 1 Gap assessment and remediation plans – a step-by-step approach. Register and access the webinar recording here: 🔗 https://rebrand.ly/6yo6juf #CencoraPharmalex #Annex1
-
-
Couldn't join the "𝗛𝗼𝘄 𝘁𝗼 𝗘𝗻𝘀𝘂𝗿𝗲 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 𝗔𝗻𝗻𝗲𝘅 𝟭" Cencora PharmaLex webinar? No problem - we recorded it for you! 🚀 Access this #webinar and learn about these challenges, based on our experiences within the industry, and how companies can have a structured approach helping them to make the assessment. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🎙️Patrick Nieuwenhuizen, Director Principal Consultant at Cencora PharmaLex 🎙️Londa R., Quality Director, Quality Management & Compliance at Cencora PharmaLex 𝗞𝗲𝘆 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀: ➡️ QRM; ➡️ CCS; ➡️ Case study examples of aging facilities; ➡️ Annex 1 Gap assessment and remediation plans – a step-by-step approach. Register and access the webinar recording here: 🔗 https://bit.ly/3t850ue #CencoraPharmalex #Annex1
-
-
QA Webinar with case study example of aging manufacturing facility and how to put in compliance measures
Couldn't join the "𝗛𝗼𝘄 𝘁𝗼 𝗘𝗻𝘀𝘂𝗿𝗲 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 #𝗔𝗻𝗻𝗲𝘅𝟭" PharmaLex webinar? No problem - we recorded it for you! 🚀 Access this #webinar and learn about these challenges, based on our experiences within the industry, and how companies can have a structured approach helping them to make the assessment. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🎙️Patrick Nieuwenhuizen, Director Principal Consultant 🎙️Londa R., Quality Director, Quality Management & Compliance Register and access the webinar recording here: 🔗 https://lnkd.in/dBctjAia
-
-
Couldn't join the "𝗛𝗼𝘄 𝘁𝗼 𝗘𝗻𝘀𝘂𝗿𝗲 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 𝗔𝗻𝗻𝗲𝘅 𝟭" Cencora PharmaLex webinar? No problem - we recorded it for you! 🚀 Access this #webinar and learn about these challenges, based on our experiences within the industry, and how companies can have a structured approach helping them to make the assessment. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🎙️Patrick Nieuwenhuizen, Director Principal Consultant at Cencora PharmaLex 🎙️Londa R., Quality Director, Quality Management & Compliance at Cencora PharmaLex 𝗞𝗲𝘆 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀: ➡️ QRM; ➡️ CCS; ➡️Case study examples of aging facilities; ➡️ Annex 1 Gap assessment and remediation plans – a step-by-step approach. Register and access the webinar recording here: 🔗 https://bit.ly/3t850ue #CencoraPharmalex #Annex1
-
-
July 25th and Christmas in July: Leap Ahead in 2024: Master CMC, Draft Potency Guidance & Upcoming ICH Updates! As we enter the latter half of 2024, there is much to accomplish before the next holidays arrive. Let Enkrisi lead you through the labyrinth of Regulatory Affairs. In this spirit of urgency and renewal, Enkrisi is poised to guide you through the nuanced intricacies of drug development and commercialization.
-
Helping the life science industry to streamline their clinical and regulatory processes.
Couldn't join the "𝗛𝗼𝘄 𝘁𝗼 𝗘𝗻𝘀𝘂𝗿𝗲 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 𝗔𝗻𝗻𝗲𝘅 𝟭" Cencora PharmaLex webinar? No problem - we recorded it for you! 🚀 Access this #webinar and learn about these challenges, based on our experiences within the industry, and how companies can have a structured approach helping them to make the assessment. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🎙️Patrick Nieuwenhuizen, Director Principal Consultant at Cencora PharmaLex 🎙️Londa R., Quality Director, Quality Management & Compliance at Cencora PharmaLex 𝗞𝗲𝘆 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀: ➡️ QRM; ➡️ CCS; ➡️Case study examples of aging facilities; ➡️ Annex 1 Gap assessment and remediation plans – a step-by-step approach. Register and access the webinar recording here: 🔗 https://bit.ly/3t850ue #CencoraPharmalex #Annex1
-
-
Helping #LifeSciences professionals| Comprehensive Pharmaceutical & Clinical Solutions eTMF| RA |QA&QC|PV|
Couldn't join the "𝗛𝗼𝘄 𝘁𝗼 𝗘𝗻𝘀𝘂𝗿𝗲 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 𝗔𝗻𝗻𝗲𝘅 𝟭" Cencora PharmaLex webinar? No problem - we recorded it for you! 🚀 Access this #webinar and learn about these challenges, based on our experiences within the industry, and how companies can have a structured approach helping them to make the assessment. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🎙️Patrick Nieuwenhuizen, Director Principal Consultant at Cencora PharmaLex 🎙️Londa R., Quality Director, Quality Management & Compliance at Cencora PharmaLex 𝗞𝗲𝘆 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀: ➡️ QRM; ➡️ CCS; ➡️Case study examples of aging facilities; ➡️ Annex 1 Gap assessment and remediation plans – a step-by-step approach. Register and access the webinar recording here: 🔗 https://bit.ly/3t850ue #CencoraPharmalex #Annex1
-
-
In the premiere episode of the Ask the Expert video series, Susan J. Schneipp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, vice president, Technical at Parexel, discuss the challenges involved in changing an excipient supplier. https://ow.ly/HsNO50Srfky
Quality Considerations in Changing Excipient Providers
biopharminternational.com
-
Couldn't join the "𝗛𝗼𝘄 𝘁𝗼 𝗘𝗻𝘀𝘂𝗿𝗲 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 #Annex1" PharmaLex webinar? No problem - we recorded it for you! 🚀 Access this #webinar and learn about these challenges, based on our experiences within the industry, and how companies can have a structured approach helping them to make the assessment. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🎙️ Patrick Nieuwenhuizen, Director Principal Consultant at #Pharmalex 🎙️Londa R., Quality Director, Quality Management & Compliance at #PharmaLex 𝗞𝗲𝘆 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀: ➡️ QRM; ➡️ CCS; ➡️Case study examples of aging facilities; ➡️ Annex 1 Gap assessment and remediation plans – a step-by-step approach. Register and access the webinar recording here: 🔗 https://bit.ly/3t850ue
-
-
Couldn't join the "𝗛𝗼𝘄 𝘁𝗼 𝗘𝗻𝘀𝘂𝗿𝗲 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 #Annex1" PharmaLex webinar? No problem - we recorded it for you! 🚀 Access this #webinar and learn about these challenges, based on our experiences within the industry, and how companies can have a structured approach helping them to make the assessment. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🎙️ Patrick Nieuwenhuizen, Director Principal Consultant at #Pharmalex 🎙️Londa R., Quality Director, Quality Management & Compliance at #PharmaLex 𝗞𝗲𝘆 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴𝘀: ➡️ QRM; ➡️ CCS; ➡️Case study examples of aging facilities; ➡️ Annex 1 Gap assessment and remediation plans – a step-by-step approach. Register and access the webinar recording here: 🔗 https://bit.ly/3t850ue
-
